“I’ve always had eczema,” says Nara Smith, a model and content creator known for her viral “from scratch” recipes. From vitamin-rich beef tallow cream to anti-inflammatory teas and ...

Atopic eczema is the most common form of eczema, affecting people of all ages but most commonly children, with 5 per cent to 15 per cent affected by the age of seven.

This study investigated the antihypertensive effects of the probiotic Lactobacillus rhamnosus strain GG (LGG) on high-salt diet-induced prehypertensive rats. Eighteen Sprague-Dawley rats were assigned ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

Tanya Dyer suffered from eczema since she was a year old. At first, it affected only the skin behind her knees and could be controlled with emollient creams. However, when she was 11, Tanya's ...

Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...

Taking Vitamin D During Pregnancy Could Lower the Risk of Eczema in Babies July 5, 2022 — Taking Vitamin D supplements during pregnancy could substantially reduce the chances of babies up to a ...

Despite numerous therapeutic research efforts, treatment of BV remains cumbersome and clinicians are currently rather poorly armed to treat BV properly in the long run. Moreover, appraisal of the ...

Bacterial vaginosis is confined to an asymptomatic state in at least half of the cases. Symptomatic BV, on the other hand, is most typically accompanied by foul-smelling, profuse vaginal discharge ...

This growing awareness has led to explosive growth in the gut health supplement market projected to reach $17.4 billion as of ...

The following is a summary of “Fluid balance and outcome in cardiac arrest patients admitted to intensive care unit,” published in the April 2025 issue of Critical Care by Renaudier et al. Researchers ...